Company profilePharmaceutical#531 of 1,318 in Pakistan✓ No DRAP alerts

Ali Industries

Pharmaceutical company · 25 brands · 23 molecules

25 registered products 24 pharmaceutical brands 23 distinct molecules 0 DRAP alerts

Company overview

25
registered products
24
pharmaceutical brands
23
distinct molecules
0
therapeutic classes
0
DRAP alerts

Ali Industries is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 25 product registrations across 23 distinct molecules. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by Ali

23 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

23
ceilings with an approval date
0
not revised in 2+ years
2025
oldest approval year
202523

Top molecules by brand count

Cefixime4 brands
Cefotaxime4 brands
Paracetamol2 brands
Paracetamol..........120Mg1 brand
Ibuprofen1 brand
Benzyl Benzoate ...... 25 %1 brand
Cefixime ...... 400 Mg1 brand

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official30 products · Rs 15.92 – Rs 496.94
Median across source: Rs 156.36

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

Hamaz Pharmaceuticals (Pvt) Ltd. holds 39 molecules not in this portfolio
AcyclovirAmoxicillinAnastrozoleAscorbic AcidAtorvastatinAzathioprine
AKSON PHARMACEUTICALS (PVT) LTD. holds 46 molecules not in this portfolio
000 I.UAmikacinArtemetherAtropineAzithromycinCefotaxime Sodium
SEMOS PHARMACEUTICALS (PVT) LTD. holds 49 molecules not in this portfolio
AmodiaquineAmodiaquine 150MgArtemetherArtesunateAscorbic AcidAzithromycin

Get the full profile for Ali

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.